Santa Clara University

Ron Haak

Industry Consultant

Ron Haak, Ph.D., has 30 years of research and development experience, most recently as Senior Vice President at Capnia, Inc., an early stage pharmaceutical company.  For the past 8 years he has been a scientific advisor and consultant to start-ups and Fortune 500 companies as well as to the Institute for OneWorld Health, a nonprofit pharmaceutical company focused on developing medicines for diseases of poverty and was a member of the board of Travanti Pharma until it was acquired in mid-2009. Prior to becoming a consultant in 2002, he was a Principal Scientist and Senior Vice President, Technology Development at ALZA Corporation, where he spent 15 years as a senior scientist and executive during its growth and ultimate merger with Johnson & Johnson. During his tenure as a Vice President, he was responsible for key aspects of several new drug applications and successfully took new drug delivery technologies from concept to product launch. Prior to that, he was a senior researcher at the Rockwell International Science Center for nine years. He received his Ph.D. in Chemistry from the University of California, Santa Barbara.  He has approximately 45 US patents and numerous scientific publications.